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Although enzyme assays, especially those för oxy-
tocinases (CAP), heat-stable alkaline phosphatase
(HSAP) and histaminase, are now thought to be
well established diagnostic tools in so-called
"placental insufficiency", opinions regarding their
usefulness for monitoring high-risk pregnancies are
still divided [11,17,23, 32]. Discrepant evaluations
are probably due to different profiles of pregnant
women studied and to the fact that only single
enzyme assays and their correlations with results
of hormonal studies are usually considered and are
seldom compared with other enzymes. The purpose
of this study was to compaie the prognostic value
of CAP and AP for endocrine monitoring of
pregnancy at neuroendocrinological risk, i.e. preg-
nancy in women with neuroendocrinological
disturbances diagnosed prior to the pregnancy
under review [24]. We are not aware of any studies
on the prognostic value of the aforementioned
enzymes in cases of this sort.
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l Case material and methods
The analysis concerns 364 pregnant women whose
pregnancies were terminated by delivery and who
had been hospitalized at the Clinic of Endo-
crinology of the Institute of Gynecology and
Obstetrics of the Medical Academy in Cracow in
the years 1971-1973. CAP was determined by
TUPPY'S method modified by KLIMEK [19] at
pH = 7.9 (P-CAP) and pH = 6.0 (T.CAP) and AP
and HSAP by KING and KING'S method modified
by HANSEN [14]. In these women, prior to the
present pregnancy, ovarian disorders and/or
sterility had been diagnosed äs the cause of failure
to become pregnant, and the majority (189
women) had been treated with hormones. Some
of the women had been treated also during the
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Fig. 1. Percentile curves and fetal danger zone of P-CAP.
No.of estimations
32 40 39 38 45 49 59 69 80 105160168 85 27 16
median
percentile2.5
'29 30 32' 34 36 3Θ 40 42 44
weeks of gestation
No.of estimatJons




30 32 34 36 38 40 42 44
weeks of gestation
Fig. 3. Percentile curves and fetal danger zone of AP.
No.of estimations









1930 3Γ 34 3f) 38 40 42 44
weeks of gestation
Fig. 2. Percentile curves and fetal danger zone of T-CAP. Fig. 4. Percentile curves and fetal danger zone of HSAP.
present pregnancy because of diabetes (9 women),
cervical incompetence (10 women), gestosis (7
women), threatened abortion (59 women), feto-
maternal immunization (3 women), or toxoplas-
mosis (25 women). Results of enzyme assays were
compared at the 95 per cent confidence level,
based on 2.5, 50.0 and 97.5 percentiles [15] with
a series of 200 healthy pregnant women who
delivered healthy children. Figs. 1—4 show the
percentile curves, smoothed out graphically, from
the calculated percentiles for each of the four
enzyme assays. Absolute values of each enzyme
activity and the curve profiles were evaluated
separately.
l.Single values: Determinations were considered
abnormal if at least one of the values was below
the 2.5 percentile (in the fetal danger zone). In
364 pregnant women, P-CAP and T-CAP were
calculated, and in 346 AP and HSAP.
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2. Serial determinations: Enzyme assays were defined by the percentage.pf women delivered of
considered abnormal if two consecutive results impaired neonates among all women with abnormal
showed a fall or remained at the same level. enzyme assays.
That is, only those women were inclüded who
had at least three enzyme assays duririg their
pregnancy: P-CAP in 157 women, T-CAP in 2 Results
149, and AP and HSAP in 134 women respec-
 The data in Tab j indicate that a low p„CAp
tivety· activity is valuable in forecasting the birth of an
Besides being evaluated according to normal or impaired or dead neonate, but not in predicting a
abnormal enzyme activity, the women were low APGAR score. Half of the women with low
divided according to whether they gave birth to activity of the enzyme will give birth to impaired
healthy or impaired neonates. An analysis was children, but a välue above percentile 2.5 does
made of all impaired or dead neonates (perinatal not exclude a threat to the infant because the
mortality, congenital anomalies, one minute sensitivity of this test is low (about 85 per cent
APGAR score below six, prematurity, intrauterine of impaired neonates are not detected). A falling
\growth retardation, respiratory distress syndrome, P-CAP curve also indjcates general impairment of
postmature fetuses, and neonates with hemolytic the neonate, but is not a prognostic sign of perinatal
disease), and separately against the rest of the mortality or of a low APGAR score. Comparison
material, perinatal mortality and low APGAR score with the single values shows that specificity of
were analyzed. Statistical analysis was made using serial assays is somewhat löWer. Only a third of
the 2 test applying YATES correction, at one women with abnormal profile of enzyme activity
degree of freedom. In addition, sensitivity and gives birth to impaired children. On the otherhand,
specificity of the enzyme assays were evaluated. the sensitivity of this test is higher, nearly 40 per
Sensitivity was definedasthe percentage of women cent of mothers of future impaired infants show
with abnormal enzyme assays among those who decreasing enzyme activity in the blood. Low
gave birth to impaired neonates. Specificity was T-CAP activity of the serum (Tab. ) also proved
Tab. I. Prognostic significance of the assays of serum placental oxytocinase activity.
No.: number of women delivered of impaired newborns
a: number öf women delivered of impaired or dead babies with of normal enzyme values (false negative test)
b: number of women delivered of impaired or dead babies whose enzyme assays were abnormal (correct test)
c: number of women delivered of normal babies whose enzyme assays were normal (correct test)
d: number of women delivered of normal newborns with abnormal enzyme assay (false positive test)
2: Chi-square test applying Yates correction :
P: probability for one degree of freedom '
N.S.:not significant
Specificity = g-^j X 100
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to be prognostic of birth of an impaired infant.
Sensitivity of this test is similar to that of P-CAP.
The differences in perinatal mortality and low
APGAR score in this group are not significant.
Falling T-CAP activity was related only to low
APGAR score and allows no conclusions concerning
impairment of the neonate in general or perinatal
mortality. Only one of every four women with
falling T-CAP activity gives birth to impaired
infants. 42 per cent of the mothers of impaired
infants, and 86 per cent of women who gave birth
to infants with a low APGAR score, had an abnor-
mal T-CAP profile during pregnancy.
Tabs. III and IV show that neither single nor serial
assays of AP and HSAP have value in predicting
neonatal impairment. Sensitivity to test was higher
for serial assays, and specificity for single ones,
similarly to CAP, but lower äs a rule than those for
both P-CAP and T-CAP.
3 Comments
Until now, evaluation of the enzyme activities
under consideration varied. The opinion prevailed
that the phosphatases have no prognostic value for
predicting the state of the neonate [10,12, 25, 29,
J. Perinat. Med. 4(1976)
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31]. Only a few authors emphasize that under
pathologic conditions, mainly in gestoses and
essential hypertension, a sudden rise or fall in
HSAP concentration may be prognostically un-
favorable [2,13, 26], and is an indication for strict
monitoring rather than for therapeutic decisions
[3]. CAPis considered by most authors to be useful
in the diagnosis of threatened pregnancy [l, 4, 5,
7, 8, 16, 18, 20, 21, 22, 28], although a few inves-
tigators hold the opposite opinion [9]. A special
application of this enzyme assay is in the diagnosis
of the hypothalamic post-pregnancy syndrome in
pregnant women [23], and the combination of
CAP with AP and cytohormonal vaginal smears
may be of value in the diagnosis of primary and
secondary placental insufficiency [30]. Thepurpose
'cif this study was to compare the prognostic and
diagnostic significance of the aforementioned
enzyme assays in pregnant women at neuroendo-
crinological risk. We have not encountered an
analysis of this type in the literature and that is
why we did not subdivide our material into
particular kinds of high-risk pregnancy which only
accompanied the neuroendocrinological risk. It
was previously found on our material that the
arithmetic means of enzyme assays in different
months of pregnancy were inversely proportional
to the degree of risk to pregnancy [30], but this
was not sufficient äs a prognostic measure of the
magnitude of risk in the event of an abnormal
assay result. In view of the above, two criteria of
abnormality have been proposed: low values and
abnormal profile. Abnormally high values, postu-
lated by some authors for CAP [27, 32] and AP
[2, 13, 26], were not taken into account because
in our material of pregnancy at neuroendocrin-
ological risk, increased fetal jeopardy was accom-
panied by decreasing enzyme activities [30]. The
results of the present analysis demonstrated prog-
nostic value of oxytocinase assays in endocrino-
logically risky pregnancy. Assays of P-CAP and
T-CAP were of almost equal significance, not-
withstanding reports of a greäter usefulness of
P-CAP [6]. On the other hand, this study confirms
that phosphatase assays are of no value prognos-
tically in neuroendocrinologically pathologic preg-
nancy. HSAP was riot superior to AP, äs some
authors have claimed. In profile studies basedupon
arithmetic means, AP was even more useful than
HSAP [30], probably owing to the greäter dis-
persion of the values of the latter. We also found
that assays of CAP are helpful in the prögriosis of
perinatal mortality and low APGAR score, i.e.
conditions that are frequently encountered in
"neuroendocrinological gestosis" [24], the term
denoting all neuroendocrinologic disturbance deve-
loped during pregnancy, including placental insuf-
ficiency, corpus luteum of pregnancy insufficiency
etc. However, about a half of futüre mothers of
impaired neonates have values outside the ränge of
these assays. This is understandable in view of the
fact that these enzyme activities reflect placental
activity but are not directly related to fetal metab-
olism. In contemporary obstetric diagnostics, they
should be supplemented by hormonal assays,
especially estriol, examination pf amniotic fluid,
ultrasonic examinations and others. If this is carried
out, unpleasant unexpected situations in the
delivery ward and neonatplotgical clinic will be
avoided. x>
Summary
Serum enzyme determinations are now well-established
diagnostic tools in so-called "placental insufficiency".
A good predictability of oxytocinases (P-CAP-placental
oxytocinase and T-CAP-tissue oxytocinase) and a doubtful
one of those of phosphatases (AP-alkaline phosphatase,
HSAP-heat stable alkaline pho'sphatase) has been shown in
high-risk pregnancies. The purpose of this study was to
determine the prognostic value of the above cited
enzymes in the so-called "pregnaricy at neuroendo-
crinological risk", i.e. pregnancy in women with a pre-
pregnancy history of hormonal disorders. It was shown
that the outcome and results of such pregnancies are
poorer that those of normal pregnancies.
The series studied comprised 364 pregnant patients with
pregnancy at neuroendocrinological risk that were being
monitored by means of serum assays of the four enzymes.
An attempt was made to assess each of these enzyme
activities both in single (at least one value below 2.5
percentile calculated for healthy subjects) and serial
determinations (two consecutive results decreasing or
remaining at the same level). Normal and abnormal
enzyme results were compared with normal and ab-
normal conditions of the newborn. The resuits presented
showed that P-CAP (Tab. I) and T-CAP (Tab. II) levels
were useful in prenatal diagnosis of fetal impaiiment in
general, in addition to perinatal mortality and low values
J. Perinat. Med. 4(1976)
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of the APGAR score. Neither the single nor serial assays
of AP (Tab. III) and HSAP (Tab. IV) were valuable in
predicting birth of an impaired neonate.
Sensitivity of the test, i.e. percentage of women with
abnormal enzyme assays among those patients who gave
birth to impaired neonates, and specificity of the test,
i.e. the percentage of women delivered of impaired
neonates among all women with abnormal enzyme assays,
of the four enzymes were compared. Sensitivity and speci-
ficity of P-CAP and T-CAP were higher than those for AP
and HSAP. Moreover, sensitivity for all four enzymes was
higher in serial assays, and specificity was higher in single
assays.
The results of the present analysis demonstrated the
prognostic value of oxytocinase assays also in the preg-
nancy at neuroendocrinological risk. Assays of P-CAP and
T-CAP were of equal significance, notwithstanding reports
of a greater usefulness of P-CAP. Assays of CAP were
helpful particularly in the conditions on which neuro-
endocrinological gestosis exerts a direct influence, i.e. in
low Apgar score and perinatal mortality. On the other
hand, serum alkaline phosphatases proved useless in
endocrine pathology of pregnancy and HSAP was not
superior to AP.
About one half of future mothers of impaired neonates
had enzyme results outside the ränge of the assays under
consideration. This could be explained by the fact that
these enzymes activities reflect placental function and
are not directly related to fetal metabolism. Because of
that they should be supplemented by other diagnostic
methods being used in a clinic of high-risk pregnancy.
Keywords: APGAR score, high-risk pregnancy, perinatal mortality, placental insufficiency, pregnancy at neuroendo-
crinological risk, serum alkaline phosphatase, serum heat-stable alkaline phosphatase, serum placental cystine
aminopeptidase, serum tissue cystine aminopeptidase
Zusammenfassung
Vergleich des prognostischen Wertes der plazentaren und
Gewebs-Oxytocinase sowie der alkalischen Phosphatase
und ihrer hitzestabilen Fraktion im Serum von Schwange-
ren mit neuroendokrinologischem fetalem Risiko
Serumenzymbestimmungen gehören heutzutage zum ein-
geführten diagnostischen Instrumentarium bei der soge-
nannten plazentaren Insuffizienz. Gute Voraussagekraft
konnte diesbezüglich bei Risikoschwangerschaften für die
Oxytocinase (P-CAP plazentare Oxytocinase und T-CAP
Gewebsoxytocinase) und zweifelhafte Aussagekraft für
die Phosphatasen (AP = alkalische Phosphatase, HSAP =
hitzestabile alkalische Phosphatase) nachgewiesen werden.
Ziel dieser Studie war es, den prognostischen Wert der
angesprochenen Enzyme bei Schwangerschaften mit so-
genanntem neuroendokrinologischem Risiko nachzu-
weisen. Dabei handelt es sich um Schwangerschaften bei
Frauen mit einer präpartalen Anamnese von Hormon^
Störungen. Es konnte gezeigt werden, daß der fetale Aus-
gang bei solchen Schwangerschaften ungünstiger ist als bei
normalen Graviditäten.
Die Serie bestand aus 364 schwangeren Frauen mit neuro-
endokrinologischen Risiko schwanger Schäften, die durch
die Bestimmung der vier Enzyme überwacht wurden. Es
wurde der Versuch unternommen, jede dieser Enzymak-
tivitäten sowohl in Einfach- (mindestens ein Wert unter-
halb der 2,5 ten Perzentile bezogen auf gesunde Indivi-
duen), sowie in Serienbestimmungen (zwei aufeinander-
folgende Meßresultate, die abfallen oder auf derselben
Höhe verbleiben) zu bestimmen. Normale und abnorme
Enzymmeßresultate wurden mit unauffälligen sowie auf-
fälligen Befunden beim Neugeborenen verglichen. Die
vorgelegten Resultate zeigen, daß die P-CAP (Tab. I) und
T-CAP (Tab. H) -Spiegel nützlich waren in der pränatalen
Diagnostik einer generellen fetalen Beeinträchtigung un-
abhängig von der perinatalen Mortalität und von tiefen
APGAR-Zahlen. Weder die Einzel- noch die Serienbe-
stimmungen der alkalischen Phosphatase (Tab. III), sowie
der hitzestabilen alkalischen Phosphatase (Tab. IV) waren
für die Voraussage eines in seinem Zustand beeinträchtig-
ten Neugeborenen brauchbar. Die Sensitivität und die
Spezifizität des Testes wurde für alle vier Enzyme mitein-
ander verglichen, d.h., der Prozentsatz an Frauen mit
nicht normalen Enzymwerten unter jenen Patientinnen,
die ein geschädigtes Kind geboren hatten und der Prozent-
satz an Frauen, die ein geschädigtes Neugeborenes hatten
innerhalb der Gruppe von Patientinnen, die alle abnormale
Enzymwerte aufwiesen. Die Sensitivität und Spezifität
der P-CAP und T-CAP war durchweg höher als jene der
AP und HSAP. Darüberhinaus zeigte sich, daß die Sensi-
tivität für alle vier Enzyme bei Serienbestimmungen höher
war, wo hingegen die Spezifität bei Einzelbestimmungen
höher lag. Die Ergebnisse der vorliegenden Analyse be-
legen den prognostischen Wert der Oxytocinasebestim-
mung auch bei Schwangerschaften mit neuroendokrino-
logischem Risiko. Die Bestimmung der P-CAP und T-CAP
war von gleichwertiger Aussagekraft, was Berichten wider-
spricht, die von größerer Brauchbarkeit der P-CAP be-
richten. Die Bestimmung der P-CAP war besonders in
jenen Situationen hilfreich, bei welchen eine neuroendo-
krinologische Gestose einen direkten Einfluß ausübte,
d.h., bei tiefen Apgarzahlen und perinataler Mortalität.
Andererseits zeigte sich die alkalische Serumphosphatase
wenig geeignet beim Vorliegen von endokrinologischer
Schwangerschaftspathologie und die HSAP war der AP
diesbezüglich nicht überlegen. Ungefähr die Hälfte der
werdenden Mütter mit geschädigten Neonaten wiesen
Enzymmeßwerte außerhalb der S treubreite für die jeweilige
Enzymbestimmung auf. Dies konnte durch die Tatsache
erklärt werden, daß diese Enzymaktivitäten die plazen-
tare Funktion widerspiegeln und nicht direkt mit dem
fetalen Metabolismus zusammenhängen. Aus diesem
Grunde sollten diese Bestimmungen durch andere dia-
gnostische Methoden ergänzt werden, die in der Klinik,
die Schwangerschaften betreut, zur Anwendung kommen.
Schlüsselwörter: APGAR-Score, alkalische Serumphosphatase, Fetus, Gewebs-Cystine Aminopeptidase, hitzestabile
Serumphosphatase, perinatale Mortalität, Plazentainsuffizienz, plazentare Cystin-Aminopeptidase,
Risikoschwangerschaft, Schwangerschaft mit neuroendokrinologischem Risiko.
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Resume
Valeur comparative de pronostic du serum-oxytocinase
placentaire et tissulaire, de la phosphatase alcaline et de sä
fraction stable a la chaleur dans les grossesses avec risque
neuroendocrinologique
Les evaluations d'enzymes du serum sont a present des
moyens eprouves pour le diagnostic de ladite «insuffisance
placentaire». Une bonne prediction d'oxytocinases
(P-CAP-oxytocinase placentaire et T-CAP-oxytocinase du
tissu) et une douteuse de celles de phosphatases (AP-
phosphatase alcaline, HSAP-phosphatase alcaline stable a
la chaleur) ont ete prouvees pour les grossesses avec un
degre eleve de risque. Cette etude a pour but d'illustrer la
valeur de pronostic des enzymes cites ci-dessus dans ladite
«grossesse a risque neuroendocrinologique», c.a.d. celle
de femmes ayant eu des troubles hormonaux avant le
debut de leur grossesse. On a vu que Tissue et les resultats
de telles grossesses sont moins bons que ceux des grossesses
normales.
Les series examinees ont porte sur 364 femmes enceintes
a grossesse avec risque neuroendocrinologique qui ont ete
contrölees au moyen de serotests des quatre enzymes. On
a essaye d'evaluer chacune de ces enzyme-activites a la
fois en determinations simples (au moins une valeur au-
dessous de 2,5 pour cent calculee pour les sujets sains) et
serielles (deux resultats consecutifs en baisse ou restant
au meme niveau). Puis on a compare les enzyme-resultats
normaux et anormaux aux conditions normales et
anormales des nouveaux-nes.
Les resultats presentes ont montre que les niveaux P-CAP
(Tab. I) et T-CAP (Tab. II) sont utiles pour le diagnostic
prenatal de troubles foetaux d.une fa$on generale, outre
la mortalite perinatale et les valeurs basses du score
APGAR. Ni les essais simples, ni ceux en serie de AP
(Tab. III) et HSAP (Tab. IV) n'ont ete valables pour faire
•
prevoir la naissance d'un nouveau-ne en mauvaise
condition.
On a compare la sensitive du test des quatre enzymes,
c.a.d. le pourcentage des femmes aux enzyme-tests
anormaux parmi les parturientes ayant donne naissance a
des nouveauxnes en mauvais etat de sant6, et la specificite
du test, c.a.d. le pourcentage des femmes ayant accouche
des nouveaux-nes non sains parmi toutes les femmes aux
enzyme-tests anormaux. La sensitivite et la specificite de
P-CAP et de T-CAP ont ete plus eleves que celles de AP
et de HSAP. De plus, la sensitivite pour les quatre enzymes
a ete plus elevee dans les essais en serie, et la specificite
plus elevee dans les essais simples.
Les resultats de Fanalyse presente ont d6montre la valeur
de pronostic des essais d'oxytocinase aussi dans la grossesse
avec risque neuroendocrinologique. Les essais de P-CAP
et de T-CAP ont ete d'egale signification, malgre les
rapports d'une plus grande utilite de P-CAP. Les tests de
CAP ont ete particulierement utiles pour illustrer les
sonditions dans lesquelles la gestose neuroendocrinologique
exerce une influence directe, c.a.d. dans ün score Apgar
bas et la mortalite perinataie. D'autre part, les serum-
phosphatases alcalines se sont revelees inutiles dans la
pathoiogie endocrinienne de grossesse et HSAP n'a pas
ete superieure a AP. A peu pres la moitie des fütures
meres de nouveaux-nes non sains ont eu des enzyme-
rosultats en dehors de la zone des essais consideeres, ce
qui a pu s'expliquer du fait que ces enzyme-activites
refletent lafonctiöri placentaire et ne sont pas directement
reliees au metabolisme foetal. A cause de cela il
conviendrait de les completer par d'autres methodes de
diagnostic utilisees dans un hopital oü sont soignees
beaucoup de grossesses avec un degre eleve de risque.
Mots-cles: Score APGAR, foetus, grossesse avec risque neuroendocrinologique, grossesse avec un degre eleve de risque,
insuffisance placentaire, mortalite perinatale, serum-aminopeptidase cystine placentaire, serum-aminopeptidase
cystine tissulaire, serum-phosphatase alcaline, serum-phosphatase alcaline stable a la chaleur.
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